Brokerages Set DRI Healthcare Trust (TSE:DHT.UN) Price Target at C$18.25

Shares of DRI Healthcare Trust (TSE:DHT.UN) have received a consensus rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is C$18.25.

Several brokerages have recently issued reports on DHT.UN. Stifel Nicolaus lowered shares of DRI Healthcare Trust from a “buy” rating to a “hold” rating and dropped their target price for the company from C$22.00 to C$15.00 in a research report on Tuesday, July 9th. Royal Bank of Canada lowered their price target on shares of DRI Healthcare Trust from C$20.00 to C$16.00 in a research report on Tuesday, July 9th. Truist Financial cut their price objective on shares of DRI Healthcare Trust from C$17.00 to C$14.00 in a report on Thursday, July 25th. Scotiabank boosted their target price on DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a report on Tuesday. Finally, National Bankshares dropped their price target on DRI Healthcare Trust from C$23.50 to C$17.50 and set an “outperform” rating for the company in a research report on Tuesday, July 9th.

DRI Healthcare Trust Trading Down 0.9 %

Shares of DHT.UN stock opened at C$14.42 on Wednesday. The business’s 50 day moving average is C$12.56 and its two-hundred day moving average is C$14.08. DRI Healthcare Trust has a 12-month low of C$10.39 and a 12-month high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 18th. Stockholders of record on Friday, October 18th will be given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 2.36%. The ex-dividend date is Friday, September 27th. DRI Healthcare Trust’s payout ratio is presently -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.